greeksoup/ stock research
Stock research / United States / TAK / Planned sales

Takeda Pharmaceutical Company Limited planned insider sales

In the last twelve months insiders at Takeda Pharmaceutical Company Limited filed 24 Form 144 notices of planned sales, 1.1 million shares worth $18.1 million at the time of filing, from 17 sellers. The latest, filed 30 October 2026: Teresa Bitetti (president, global oncology business unit), 46,609 shares worth $940,104, planned for around 1 November 2026 through Interactive Brokers LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
30 October 2026Teresa BitettiPresident, Global Oncology Business Unit46,609$940,1041 November 202646,609 shares from 2 November 2026Interactive Brokers LLCRestricted Stock Unit Awards - VestedForm 144
30 October 2026Platford Giles RichardPresident, International Business Unit55,617$1.1 million1 November 202655,617 shares from 4 November 2026Interactive Brokers LLCRestricted Stock Unit Awards - VestedForm 144
10 September 2026Lauren Rusckowski DupreyChief Transformation Officer34,535$634,40810 September 202634,535 shares from 14 September 2026Interactive Brokers LLCRestricted Stock Unit Awards - VestedForm 144
2 September 2026Plump Andrew StewartOfficer116,191$2.1 million2 September 2026116,191 shares from 2 September 2026Fidelity Brokerage Services LLCRSU's and PSU'sForm 144
19 August 2026Plump Andrew StewartOfficer19,651$363,34819 August 202619,651 shares from 19 August 2026Fidelity Brokerage Services LLCRSU's and PSU'sForm 144
14 August 2026Nicola GreenwayChief Human Resources Officer12,980$225,72214 August 202612,980 shares from 18 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - VestedForm 144
10 August 2026Elaine ShannonPresident, Global Supply & Quality20,363$355,33411 August 202624,341 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - VestedForm 144
6 August 2026Nicola GreenwayChief Human Resources Officer34,603$578,5627 August 202641,377 shares from 10 August 2026Interactive Brokers LLCEmployee Stock Purchase Plan; Restricted Stock Unit Awards - VestedForm 144
13 July 2026Elaine ShannonPresident, Global Supply & Quality4,319$72,35113 July 2026No matching Form 4 saleInteractive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Nicola GreenwayChief Human Resources Officer7,348$123,07213 July 2026No matching Form 4 saleInteractive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Ramy RiadPresident, Plasma-Derived Therapies Business Unit7,889$132,14913 July 20267,277 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Awny FarajallahChief Medical Officer15,188$254,39913 July 202614,006 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Rhonda PachecoPresident, US Business Unit and US Country Head18,316$306,78913 July 202616,901 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Marcello Pignagnoli AgostiInterim Head, Strategy and Portfolio Development24,887$416,85013 July 202622,957 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Gabriele RicciChief Data & Technology Officer27,197$455,54513 July 202625,088 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Natalie FurneyGlobal General Counsel33,454$560,35113 July 202630,868 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Giles PlatfordPresident, International Business Unit33,696$564,40613 July 202631,083 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Lauren Rusckowski DupreyChief Transformation Officer51,579$863,94713 July 202647,586 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Teresa BitettiPresident, Global Oncology Business Unit54,210$908,01913 July 202650,012 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Julie KimPresident and CEO96,558$1.6 million13 July 202689,090 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
13 July 2026Andrew PlumpPresident, Research & Development179,239$3.0 million13 July 2026165,393 shares from 10 August 2026Interactive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
9 December 2025Lauren Rusckowski DupreyChief Human Resources Officer29,619$421,1829 December 2025No matching Form 4 saleInteractive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
5 December 2025Teresa Marie BitettiPresident, Global Oncology Business Unit87,023$1.2 million5 December 2025No matching Form 4 saleInteractive Brokers LLCRestricted Stock Unit Awards - Vested.Form 144
4 December 2025Giles Richard PlatfordPresident, Plasma-Derived Therapies Business Unit58,421$836,0054 December 2025No matching Form 4 saleInteractive Brokers LLCRestricted Stock Unit Awards - VestedForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?